156 related articles for article (PubMed ID: 11788028)
1. Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection.
Burkhard MJ; Mathiason CK; Bowdre T; Hoover EA
AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1767-78. PubMed ID: 11788028
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
3. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route.
Burkhard MJ; Mathiason CK; O'Halloran K; Hoover EA
AIDS Res Hum Retroviruses; 2002 Feb; 18(3):217-26. PubMed ID: 11839157
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats.
Burkhard MJ; Valenski L; Leavell S; Dean GA; Tompkins WA
Vaccine; 2002 Dec; 21(3-4):258-68. PubMed ID: 12450701
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
7. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
Beatty JA; Willett BJ; Gault EA; Jarrett O
J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
[TBL] [Abstract][Full Text] [Related]
9. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
10. Selective thymocyte depletion and immunoglobulin coating in the thymus of cats infected with feline immunodeficiency virus.
Orandle MS; Papadi GP; Bubenik LJ; Dailey CI; Johnson CM
AIDS Res Hum Retroviruses; 1997 May; 13(7):611-20. PubMed ID: 9135879
[TBL] [Abstract][Full Text] [Related]
11. Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus.
Tijhaar EJ; Huisman W; Huisman RC; Siebelink KH; Karlas JA; de Ronde A; van Herwijnen R; Mooi FR; Osterhaus AD
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3265-75. PubMed ID: 9400977
[TBL] [Abstract][Full Text] [Related]
12. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.
Flynn JN; Cannon CA; Neil JC; Jarrett O
J Virol; 1997 Oct; 71(10):7586-92. PubMed ID: 9311839
[TBL] [Abstract][Full Text] [Related]
14. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.
Finerty S; Stokes CR; Gruffydd-Jones TJ; Hillman TJ; Barr FJ; Harbour DA
Vaccine; 2001 Oct; 20(1-2):49-58. PubMed ID: 11567745
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus.
Stevens R; Howard KE; Nordone S; Burkhard M; Dean GA
J Virol; 2004 Aug; 78(15):8210-8. PubMed ID: 15254192
[TBL] [Abstract][Full Text] [Related]
16. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
17. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.
Toyosaki T; Miyazawa T; Furuya T; Tomonaga K; Shin YS; Okita M; Kawaguchi Y; Kai C; Mori S; Mikami T
Arch Virol; 1993; 131(3-4):335-47. PubMed ID: 8102229
[TBL] [Abstract][Full Text] [Related]
18. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
19. Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24Gag.
Leavell S; Wright B; Scappino L; Sirriyah J; Chen C; Clements JD; Burkhard MJ
Vaccine; 2005 Feb; 23(12):1471-8. PubMed ID: 15670883
[TBL] [Abstract][Full Text] [Related]
20. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.
Flynn JN; Cannon CA; Beatty JA; Mackett M; Rigby MA; Neil JC; Jarrett C
J Virol; 1994 Sep; 68(9):5835-44. PubMed ID: 8057464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
